William N. Starling

William N. Starling is managing director of Synergy Life Science Partners, and chief executive officer of Synecor, a business generator of new life–science companies. He has raised more than $300 million in capital for companies he co–founded – the combined revenues of which now reach nearly $3 billion annually. As CEO of Synecor, Mr. Starling co–founded Asensus as well as BaroSense, Bioerodible Vascular Solutions (acquired by Guidant/Abbott in April 2004), InnerPulse and Interventional Autonomics Corp. Mr. Starling serves as board chairman of InnerPulse, board chairman of Interventional Autonomics Corp., and as a board member of Asensus.

Mr. Starling began his 30–year career in medical technologies at American Edwards Laboratories (now Edwards LifeSciences). There, he was part of the founding management team, served as marketing director for Advanced Cardiovascular Systems Inc. (acquired by Guidant/Abbott) and was co-founder, vice president and board member of Ventritex Inc. (acquired by St. Jude Medical). In addition, Mr. Starling was a co–founder, board chairman, and president and CEO of Cardiac Pathways Corp. (acquired by Boston Scientific Corp.).